Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Flagship Ventures Fund V

Realizing entrepreneurial innovation is the mission of Flagship Ventures. Founded in 2000, the firm has launched 30 companies while investing in another 50. Flagship manages $1.4 billion in capital and is active in three principal sectors: therapeutics, health technologies, and sustainability. Flagship’s current portfolio includes Acceleron (NASDAQ: XLRN), Agios (NASDAQ: AGIO), BIND Therapeutics (NASDAQ: BIND), Concert Pharmaceuticals (NASDAQ: CNCE), Eleven Biotherapeutics (NASDAQ: EBIO), T2 Biosystems (NASDAQ: TTOO), Tetraphase (NASDAQ: TTPH) as well as several private companies: Editas Medicine, Pronutria Biosciences, Seres Health and Moderna Therapeutics. *

 

Period Start 2015-03-01 closing
  Group Flagship Pioneering
Products Industry venture capital
  Industry 2 HEALTH (HUMAN)
     
Region Region Cambridge, MA
  Country United States (USA)
  Street 1 Memorial Drive
7th Floor
  City 02142 Cambridge, MA
  Tel +1-617-868-1888
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
  Currency USD
  Annual sales 537,000,000 (capital under management 2015-03-01)
     
    * Document for »About Section«: 
     
   
Record changed: 2021-05-24

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Flagship Pioneering


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x300px




» top